心房纤颤(简称房颤)是临床最常见心律失常之一,随着老龄人口的增加,房颤的发生率逐渐提高。目前,药物治疗仍是房颤的重要治疗手段。我们用稳心颗粒联用缬沙坦治疗50例老年阵发性房颤患者,与胺碘酮治疗的46例对比,探索稳心颗粒联用缬沙坦治疗阵发性房颤的疗效和安全性。1临床资 Atrial fibrillation (referred to as atrial fibrillation) is one of the most common clinical arrhythmia, with the aging population increased, the incidence of atrial fibrillation gradually increased. At present, drug treatment is still an important treatment of atrial fibrillation. We use the steady heart particles combined with valsartan in 50 cases of elderly patients with paroxysmal atrial fibrillation, compared with 46 cases of amiodarone treatment, to explore the stability of particles combined with valsartan in the treatment of paroxysmal atrial fibrillation efficacy and safety Sex. 1 clinical resources